• Blog
  • Digital Pathology Market Report

    Digital Pathology Market Report

    Digital Pathology Market Report
    Report code - SRHL205 Delivery - 2 Weeks
    Get Free Sample |
    Play Audio
    Listen
    Global Digital Pathology Market, Trends, Dynamics, Market Analysis
    See more...

    Market Insights

    The Global Digital Pathology Market is projected to grow from USD 585.2 million in 2020 to USD 1,230.6 million by 2026 at a CAGR of over 13.2% during the forecast period.            

    Figure: Global Digital Pathology Market Size, 2020-2026 (USD Million)

    Digital-Pathology-Market-Forecast

    Want to know the full scope of the report? Register Here

    What is Digital pathology?

    Digital pathology is referred to as an image-based information setting that is enabled by computer technology which allows management of information generated via a digital slide. Digitalization of pathology has further led to the automation of tests during disease diagnosis among other applications. A single digital device can perform tests that were previously carried out using five instruments by pathologists. These solutions offer analysis & scrutiny of images on a computer, online storage of digital slides, and high-resolution sample scanning, which helps the pathologists to cross-examine slides without physical evidences.

    Key Players

    Key players operating in the global digital pathology market are-

    • Danaher (The U.S.),
    • Hamamatsu Photonics, Inc (Japan),
    • Koninklijke Philips N.V. (Netherlands),
    • Olympus Corporation (Japan),
    • F. Hoffmann-La Roche Ltd (Switzerland),
    • Mikroscan Technologies (The U.S.),
    • Inspirata, Inc (The U.S.),
    • Visiopharm A/S (Denmark),
    • Huron Digital Pathology (Canada), and
    • 3DHISTECH Ltd. (Hungary).

    Market Dynamics

    Increasing efficiency of digital pathology systems, ease of virtual transportation of slides, and efficient cost of digital pathology products are the key factors augmenting the market growth. Moreover, the surge in initiatives toward commercialization of cost-effective digital pathology systems is further expected to create lucrative opportunities for the market players during the review period. However, a lack of skilled professionals and unclear reimbursement policies are expected to hamper the industry expansion.

    Segment Analysis

    Product Trends

    Based on product, the global digital pathology market has been segmented into software, device, storage, and system. Among these, the device segment witnessed the highest market share in 2020 and is projected to register a healthy CAGR during the assessment period. This is mainly ascribed to the rise in academic research activities and improved resolution of slide management systems and scanners, thereby bolstering the segment growth.

    Regional Trends

    By region, the North American market accounted for the largest market share of over 40% in 2020 and is likely to grow at a robust CAGR during the review period. This can be attributed to supportive government initiatives about the development of technologically advanced systems, continual deployment of R&D investments, growing adoption of digital imaging, and the presence of major players boosting the industry growth in the region.

    COVID-19 Impact on Global Digital Pathology Market

    The COVID-19 pandemic has positively influenced the digital pathology industry. Government bodies across the globe are focusing to curb the COVID-19 with important measures, such as social distancing, nationwide lockdowns, and large-scale quarantine to prevent the spread of the coronavirus. This pandemic has further created immense opportunities for the industry participants involved in digital pathology. For instance, U.S. FDA’s Center for Devices and Radiological Health released an enforcement policy for remote digital pathology devices proposed for pathologists, drug administration staff, clinical laboratories, and healthcare facilities.

    Critical Questions Answered in the Report

    • What are the key trends in the global digital pathology market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the global digital pathology market?
    • What are the key strategies adopted by the major vendors to lead in the global digital pathology market?
    • What is the market share of the top vendors?

    Get the full scope of the report.Register Here

    Target Audience

    The following is a list of the customers that the Digital Pathology market aims to convert the most:

    • Digital pathology companies
    • Hospitals
    • Biotech & pharma companies
    • Diagnostic Labs
    • Research Centers & Organizations

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].

    Frequently Asked Questions (FAQs)

    The digital pathology market is expected to witness an impressive growth of 13.2% CAGR in the foreseeable future.

    The digital pathology market is expected to reach USD 1,230.6 million in the coming year.

    Danaher (The U.S.), Hamamatsu Photonics, Inc (Japan), Koninklijke Philips N.V. (Netherlands), Olympus Corporation (Japan), F. Hoffmann-La Roche Ltd (Switzerland), Mikroscan Technologies (The U.S.), Inspirata, Inc (The U.S.), Visiopharm A/S (Denmark), Huron Digital Pathology (Canada), and 3DHISTECH Ltd. (Hungary) are among the key players in the digital pathology market.

    Increasing efficiency of digital pathology systems, ease of virtual transportation of slides, and efficient cost of digital pathology products are the factors driving the growth of digital pathology market.

    North American market accounted for the largest market share of over 40% in 2020 and is likely to grow at a robust CAGR.

    Device segment witnessed the highest market share in 2020 and is projected to register a healthy CAGR.

    Digital pathology companies, Hospitals, Biotech & pharma companies, Diagnostic Labs, Research Centers & Organizations are the target audience in the digital pathology market.

    •